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Abstract: Primary hepatocellular carcinoma (HCC) is currently the ﬁ  fth most common malignancy and the third most 
common cause of cancer mortality worldwide. Because of its high prevalence in developing nations, there have been numer-
ous efforts made in the molecular characterization of primary HCC. However, a better understanding into the pathology of 
HCC required software-assisted network modeling and analysis. In this paper, the author presented his ﬁ  rst attempt in 
exploring the biological implication of gene co-expression in HCC using actor-semiotic network modeling and analysis. 
The network was ﬁ  rst constructed by integrating inter-actor relationships, e.g. gene co-expression, microRNA-to-gene, and 
protein interactions, with semiotic relationships, e.g. gene-to-Gene Ontology Process. Topological features that are highly 
discriminative of the HCC phenotype were identiﬁ  ed by visual inspection. Finally, the author devised a graph signature-
based analysis method to supplement the network exploration.
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1. Introduction
Primary hepatocellular carcinoma (HCC) is the ﬁ  fth most common malignancy and the third most 
common cause of cancer mortality worldwide with one million new cases diagnosed annually. Its 
prevalence is much higher in developing nations than in industrialized nations. At present, 80% of the 
HCC cases came from the East Asia and the sub-Saharan Africa with China accounting for nearly 55% 
of them [1]. For this reason, there have been numerous efforts made in the molecular characterization 
of primary HCC. As a result, there is a rich repository of genomic and proteomic data available for 
public access [2]. To uncover the biology hidden within such a large volume of data will require software-
assisted network modeling and analysis (reviewed in [3]). In recent years, attempts to characterize 
disease phenotypes by integrative network modeling and analysis have been made. For example, Tuck 
et al. [4] retrieved the human gene regulatory network from the TRANSFAC
® database and integrated 
it with the transcription factor-to-target genes co-expression network derived from multiple microarrays. 
They then demonstrated that node degree measures are a feasible discriminator of oncology types. 
Chuang et al. [5] characterized proteomic sub-networks as the biomarkers for discriminating between 
metastatic and non-metastatic breast cancer. They demonstrated that the protein sub-networks identiﬁ  ed 
are highly discriminative of metastasis and some of the genes underscored by statistical inference 
methods were found to be member nodes of those sub-networks. These studies demonstrated the effec-
tiveness of network modeling and analysis.
This paper presents the author’s ﬁ  rst attempt in exploring the biological implication of gene co-
expression in HCC using actor-semiotic network modeling. The rationale was that a complex network 
requires context or metadata to be comprehensible. Without which, no human user would be able to 
unpack the information content within, let alone making biological deductions. The proposed actor-
semiotic network is similar to the actor-network [6] frequently used for modeling healthcare systems. 
Actor-network theory models the human community as a network of heterogeneous actor-semiotic 
interactions. The actors are human participants, human organizations, and material objects. The semiotics 
is the human ideas, concept, and policies. In molecular biology, the actors are the bio-molecules and 
the sub-cellular components. The semiotics is the human understanding of biology. Its abstraction is 464
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the ontologies on biological processes, molecular 
function, and cellular phenotypes.
Because the topology of an actor-semiotic 
network is determined by the combination of 
inter-actor and semiotic relationships, there should 
be visually identiﬁ  able topological features that 
are highly discriminative of the HCC phenotype. 
To achieve this, the author employed visual 
inspection and, in addition, a graph signature-
based analysis method to supplement network 
exploration. This method ﬁ  rst summarized the 
local topology of every node in the network as a 
signature vector and then projected the vectors 
onto a two-dimensional scatterplot for further 
exploration.
2. Topological Analysis 
of the Actor-Semiotic Network
2.1. Visual analysis
Using NetMap Decision Director™, an actor-
semiotic network G (|V| = 9313; |E| = 49,393) was 
being constructed. G was a union of all the actor and 
semiotic nodes and edges described in section 6.2. 
The bio-molecules and the sub-cellular components 
within G were represented by the actor nodes 
whereas the biological context of G was represented 
by the semiotic nodes (see Appendix A.1). The 
pairwise interactions between bio-molecules or 
between bio-molecules and sub-cellular components 
were represented by the inter-actor edges. The onto-
logical relationships between actor and semiotic 
nodes were represented by the semiotic edges.
A smaller network G’ (|V| = 1668; |E| = 2473) was 
derived from G as a result of node mapping (see 
Appendix A.2 and Fig. 1). To test whether G’ 
contained a set of nested networks, it was decom-
posed to Gd using NetMap™. The nested networks 
observed in Gd are discrete clusters. Let Ck be one 
of the clusters, then Gd = {Ck} where 0  k  32 
(Fig. 2). Each cluster is a network that is not con-
nected to any other clusters nor does it share any of 
its member nodes with other clusters, such that Ci ∩ 
Cj = 0 for Ci, Cj ⊆ {Ck} where i ≠ j. Although their 
size |V| ranged from 2 to 1536, only one cluster had 
a |V| of 1536. The rest had a |V| that ranged from 2 to 7. 
Among the inter-actor edges in the small clusters 
(1  |V|  8), only 10 were of the Coexpression_
HCC subtype and 24 were of the Coexpression_liver 
subtype. It showed that most co-expressed genes, 
whether in the normal hepatocyte or in HCC, are 
highly inter-connected. Eight of the small clusters 
contained only semiotic edges. For the small clusters 
that contained at least one inter-actor edge, the semi-
otic nodes indicated that the protein-coding genes 
within each cluster shared the same biological pro-
cess or molecular function (Fig. 2).
From the largest cluster Ge (|V| = 1536; |E| = 2367) 
in Gd, the largest connected component 
Ge’ (|V| = 1371; |E| = 1120) was extracted (Fig. 1). 
Ge’ was comprised of inter-connected emergent 
groups and liaison nodes (Fig. 3). An emergent 
group is a sub-network in which its member nodes 
are more inter-connected within than without. A liai-
son node is a node shared by multiple emergent 
groups. The emergent groups were localized in the 
top half and the liaison nodes in the lower half of Ge’. 




Figure 1. Exploring the actor-semiotic network of HCC. (1) The network G was reduced to a smaller network G’ by excluding extraneous 
Protein nodes and Gene Ontology nodes that did not map to the Gene nodes in the co-expression network. (2) G’ was transformed to Gd to 
expose any nested discrete clusters. (3) The largest connected component Ge’ was extracted from Ge which is the largest cluster in Gd. Node 
centrality signature vectors of Ge’ were constructed before biological inference.465
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Of the 41 emergent groups, six of them had a |V| 
larger than 25. The semiotic edges within each emer-
gent group indicated that it belongs to a speciﬁ  c 
biological process showing that the topology of the 
integrated co-expression and protein interaction 
network in HCC is partially modular. In a sense, each 
emergent group is similar to the Complex Biological 
Module proposed by Zotenko et al. [30]. Some emer-
gent groups, e.g. groups 4 and 5, are directly linked 
to one another suggesting that the coupling between 
their corresponding biological processes could be 
hard-wired. Some, e.g. groups 2 and 3, are connected 
via liaison nodes, MAPK1 and MIRN217, suggesting 
that the coupling between their corresponding bio-
logical processes could be switch-dependent.
2.2. Network exploration using 
graph signatures
The eccentricity and radiality centralities were found 
to give identical rankings. The same was also 
observed with the HITS-Authority and HITS-Hub 
centralities. Therefore the radiality and the HITS-
Hub centralities were excluded from the signature 
vector of each node. After the signature vectors were 
computed and scaled, the scatterplot shows that there 
are two clusters of nodes, each representing a differ-
ent range of signature vectors (Fig. 4). Nodes within 
the emergent groups were found in the upper cluster 
and liaison nodes were found in the lower cluster.
The six nodes at the left-extremity (x-range = 
[−1661.93, −1617.66]; y-range = [−74.14, 61.57]; 
Fig. 4) of the lower cluster have signatures that con-
tained the top 5% ranking in closeness, current-ﬂ  ow 
betweenness, current-ﬂ  ow closeness, and shortest-
path betweenness centralities. Three of these nodes 
GGA3, IPO7 and RAN are members of emergent 
group 2 (Fig. 3). They are involved in intracellular 
trafﬁ  cking. Another two, CTGF and CYR61 are liaison 
nodes involved in angiogenesis. The last one, MAPK1 
is also a liaison node which is an ampliﬁ  er shared by 
multiple signal transduction pathways. The four nodes 
Figure 2. Network topology of Gd. Gene co-expression in the normal hepatocyte is represented by green-coloured edges whereas co-
expression in the hepatocellular carcinoma is represented by dark red-coloured edges. Gene nodes are coloured dark red. GO nodes are 
coloured yellow. MIRNA nodes are coloured blue.466
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Figure 3. Network topology of Ge’. The colour coding used for nodes and edges is the same as in Figure 2. The rank scores for the seven 
centrality types in each bar chart are arranged (from left to right) in this order: Degree, Closeness, Current Flow-Betweenness, Current 




















































Figure 4. Scatterplot generated by projecting graph signatures of Ge’ to the 2D space using Kruskal’s multi-dimensional scaling.467
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at the right-extremity (x-range = [1620.29, 1719.54]; 
y-range = [−125.71, −184.45]; Fig. 4) of the upper 
cluster have signatures that contain the bottom 10% 
ranking in all seven centrality types. Two of them, 
NDUFB5 and PSMB9, are actor nodes. Another two, 
GO:0051538 (3 iron, 4 sulfur cluster binding) and 
GO:0051881 (regulation of mitochondrial mem-
brane potential), are semiotic nodes. NDUFB5 is a 
subunit of the ubiquinone complex in the mitochon-
drial electron transport chain whereas PSMB9 is a 
proteosome subunit. Both proteins are peripheral 
nodes in the emergent group 6 (Fig. 3).
The three nodes at the bottom corner of the 
lower cluster (x-range = [119.32, 173.93]; y-range = 
[−1570.32, −1597.41]; Fig. 4) have signatures that 
contain the bottom 10% ranking in closeness, cur-
rent-ﬂ  ow closeness, eccentricity, and HITS-author-
ity centralities, and the top 10% ranking in degree, 
current-flow betweenness, and shortest-path 
betweenness centralities. They are COX17, 
NDUFS1, and DLD. Each of these nodes was a 
junction to two small subsets of nodes with each 
subset containing a maximum of three nodes. Yet 
at least one node within each subset was connected 
to another two nodes without. COX17 and NDUFS1 
are subunits of the mitochondrial electron transport 
chain with the latter being another subunit of the 
ubiquinone complex. DLD is a subunit of the pyru-
vate dehydrogenase complex. The semiotic node 
at the top corner of the upper cluster (x = [225.65]; 
y = [1223.89]; Fig. 4) is GO:0050672 (negative 
regulation of lymphocyte proliferation). It had a 
signature that contain the bottom 10% ranking in 
degree, current-ﬂ  ow betweenness, and shortest-
path betweenness centralities, the top 10% ranking 
in closeness and eccentricity centrality, and the top 
5% ranking in HITS-authority centrality.
In summary, the ranking of all centralities 
decreases as one moves to the right end of the 
x-axis in the scatterplot. On the other hand, the 
node ranking on degree, current-ﬂ  ow betweenness, 
and shortest-path betweenness centralities increase 
as one moves to the lower end of the y-axis but at 
the same time, the rankings on closeness, current-
ﬂ  ow closeness, eccentricity, and HITS-authority 
centralities decrease. The rank score of those nodes 
mentioned in this paper are tabulated in Table 1.
3. Inference of HCC Biology
Based on the visual exploration of network Ge’ and 
the inspection of the scatterplot, the author deduced 
several hypotheses on the molecular pathology of 
HCC as described in the following sections. Since 
cell cycle events have been well studied in recent 
years, emergent group 3 was used to demonstrate 
that the actor-semiotic network is a model consis-
tent with the current knowledge on cell prolifera-
tion. MicroRNAs have recently been discovered as 
new players in regulating oncogenic signal trans-
duction. In section 3.2, the author hypothesized the 
inﬂ  uence of MIRN18A on angiogenesis in HCC and 
how this could contribute to tumor invasiveness. 
Also gaining attention lately is the role of intracel-
lular trafficking in establishing the malignant 
phenotype. In section 3.3, the author hypothesized 
the possible effect of nuclear export disruption on 
growth factor-induced gene regulation.
3.1. De-synchronized cell cycle phases
The semiotic nodes in emergent group 3 indicated 
that it contains exclusively cell cycle genes 
(Fig. 3). Their co-expression was found only in 
HCC and could be a result of replication stress. 
Within this emergent group, UBE2C has the high-
est node degree centrality. Of interest, UBE2C 
up-regulation has frequently been observed in a 
variety of malignancies including HCC [2, 7]. 
UBE2C was found to link with three semiotic 
nodes, GO:0007051 (spindle organization), 
GO:0008054 (cyclin catabolism), and GO:0031536 
(positive regulation of mitotic exit), as compared 
to only one or two seen among its co-expressed 
neighbours. Hence UBE2C is functionally more 
diverse but still operates exclusively within the 
cell cycle. This agrees with the consensus that 
UBE2C, an E2-ubiquitin conjugating enzyme, is 
a subunit of the anaphase promoting complex 
(APC/C) which mediates substrate ordering [8]. 
Substrate ordering refers to the proper sequence 
of protein ubiquitination that ensures the orderly 
degradation of different proteins during cell cycle 
progression. It has been known that APC/C inac-
tivation is mediated by UBE2C auto-ubiquitination, 
a result of UBE2C up-regulation [9]. If this 
up-regulation is persistent in HCC, APC/C inac-
tivation could be prolonged beyond the S phase. 
One probable effect would be the reduction in 
cyclin catabolism which could lead to a shortened 
G1 phase and a prolonged S phase due to the dis-
ruption in DNA replication [10]. With the loss of 
substrate ordering, the author hypothesized that 
the cell cycle phasing would be de-synchronized. 468
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Molecular events that are S phase speciﬁ  c could 
co-exist with those in the G2 and M phases. Even-
tually, mitotic exit could be delayed or even 
failed.
3.2. Abnormal angiogenesis
CYR61 (CCN1) and CTGF (CCN2) were found to 
co-express with TGFB1 in HCC only. Both belong 
to the CCN family of immediate early genes 
activated by TGFβ1 [11] and by hypoxia [12]. 
Previous work suggested that CYR61 induces 
endothelial cell proliferation, cell adhesion, and 
angiogenesis through the activation of integrin 
(ITGAV-ITGB3 complex) expression [13]. CTGF 
induces the secretion of collagen and ﬁ  bronec-
tin which form the scaffolding of the extracellular 
matrix, a step crucial to the formation of a 
Table 1. Node centrality ranking of actor and semiotic nodes in Ge’.
Node name Degree Closeness Current ﬂ  ow 
betweenness






CTGF 56 11 7 10 317 119 9
COL6A1 166 139 359 102 463 228 467
COX17 167 1285 62 1292 1270 1313 33
CDKN2A 165 271 21 281 159 221 39
CYR61 95 7 29 20 162 150 6
CXCR4 3 34 5 16 465 23 7
DLD 42 1317 177 1317 1302 1326 84
GGA3 16 5 2 3 58 374 2
IPO7 26 2 10 1 19 443 4
MAPK1 33 1 3 12 2 515 1
MIRN18A 1314 99 695 310 574 210 1301
MIRN148A 567 39 204 180 20 431 164
MIRN148B 568 40 205 181 21 432 165
MIRN217 570 6 103 119 3 650 18
MIRN375 573 30 43 118 265 209 36
MMP17 366 571 493 577 575 603 380
NDUFB5 1322 1371 1315 1370 1371 1371 1311
NDUFS1 142 1313 77 1313 1298 1324 44
PSMB9 1336 1340 1323 1351 1326 1341 1328
RAN 27 4 8 2 119 444 8
RPL6 7 136 291 85 127 66 242
RPL9 28 198 235 86 128 68 259
RPL14 36 201 343 98 123 71 347
RPL15 37 228 150 94 124 73 108
RPL31 6 135 269 78 125 65 243
TGFB1 71 462 368 712 980 169 229
UBE2C 39 80 169 45 301 613 177
GO:0050672 1264 193 1285 299 924 47 1245
GO:0051538 1288 1350 1299 1354 1345 1350 1269
GO:0051881 1293 1321 1301 1331 1305 1330 1274
The actor nodes are listed in the alphabetical order of their gene symbols. The semiotic nodes are listed in the alphanumerical order of the 
Gene Ontology ID. The rank score for each centrality type ranges from 1 to 1372. A lower rank score means a higher node ranking for a 
particular centrality type.469
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neo-vasculature [14]. That explained why it is 
directly linked to COL6A1 and COL6A3 in emer-
gent group 7. As shown in the lower right inset of 
Figure 3, CTGF is a predicted target of MIRN18A. 
This microRNA gene, which has been found to 
express in some Japanese HCC patients, is both 
liver- and tumor-speciﬁ  c [15]. The author hypoth-
esized that the expression of MIRN18A in HCC 
could lead to matrix instability due to the reduced 
translation of CTGF transcripts. The dynamics of 
angiogenesis could therefore be altered if the 
molecular abundance of CYR61 is higher than that 
of CTGF. One consequence could be excessive 
endothelial cell migration and proliferation but 
inadequate cell anchorage due to an unstable extra-
cellular matrix and hence poor tubular formation. 
Tumor vasculature is known to be structurally 
chaotic with excessive leakage [16] and MIRN18A 
expression could be a contributing factor. This may 
enhance HCC metastasis in two ways. The ﬁ  rst 
could be enhanced tissue invasion by MMPs 
induced by the hepatitis B viral oncoprotein HBX 
in malignant cells [17]. The second could be the 
intravasation of malignant cells into the neo-
vasculature but also rapid extravasation to the 
surrounding tissue because of vascular leakage.
3.3. Disrupted nuclear transport
IPO7 and RAN were found to co-express not only 
with each other but also with nine other protein-
coding genes (emergent group 2; Fig. 3). The 
semiotic nodes indicated that they are all involved 
in intracellular trafﬁ  cking. Their co-expression 
occurred only in normal hepatocytes suggesting 
that intracellular trafﬁ  cking could be aberrant in 
HCC. One possible cause could be the disruption 
of nucleocytoplasmic trafﬁ  cking by HBX. Spe-
ciﬁ  cally, HBX disrupts nuclear export by seques-
trating the export receptor XPO. Furthermore, the 
nuclear import and export processes require the 
GTPase protein RAN. It controls the interaction of 
XPO and of the importin receptor IPO7 with their 
target proteins [18]. If the majority of the XPO in 
HCC is being inactivated by HBX, it is possible 
that there will be a surplus of RAN available for 
mediating nuclear import by IPO7.
Recent ﬁ  ndings revealed that many growth 
factors, e.g. CTGF, CYR61, EGF, FGF, IFNG, and 
their cell surface receptors can be endocytosed, 
then imported into the nucleus by importin recep-
tors, and eventually exported by exportin receptors 
(reviewed in [19]). Within the nucleus, they interact 
with various transcription factors, e.g. E2F1 and 
STAT3, or co-regulators [20]. Apart from regulating 
the transcription of speciﬁ  c target genes, they could 
also be involved in DNA replication [21] and repair 
[22], and RNA metabolism [23]. Therefore the 
author hypothesized that the HBX-induced imbal-
ance between nuclear import and export volumes 
could prolong growth factor activities inside the 
nucleus. Already, there have been studies suggest-
ing that, at least for FGFs and EGFs, prolonged 
nuclear localization is correlated with cancer pro-
gression, resistance to radiotherapy and conse-
quently poor prognosis [24].
4. Discussion
4.1. Strength and limitations 
of network analysis
Network analytics is very suited to biomedical 
research where high informational granularity and 
connectivity between objects are required for 
knowledge inference. However, the scale of the 
network often presents a cognitive challenge to the 
analyst. This limitation is partly moderated with 
the use of NetMap™ which allows the analyst to 
downsize a large network (|V|  5000; |E|  5000) 
by excluding nodes and edges selectively and then 
extract any sub-networks for further analysis. The 
2D-projection of graph signatures further moder-
ates the challenge of scale by providing a visual 
summary on the surrounding topology of every 
node in the form of a scatterplot. Using the latter 
as a guide, the analyst can then prioritize the nodes 
that need to be inspected ﬁ  rst. At present, the author 
is testing this approach with networks that 
contained human disease terms [25] and cellular 
quiescence phenotypes [26] as semiotic nodes to 
see if one can discover more insights into the 
molecular pathology of HCC.
4.2. Biological implication of node 
centrality
There have been several views on how node cen-
tralities signify the biological essentiality of a 
protein. The ﬁ  rst view took degree centrality as the 
primary indicator of biological essentiality because 
high degree protein nodes, also known as hubs, are 
essential for maintaining network connectivity 
[27]. The second view argued that shortest-path 470
Fung
Cancer Informatics 2008:6
betweenness centrality is a better indicator of 
essentiality [28]. This view suggested that bottle-
neck proteins linked to multiple protein hubs are 
also biologically essential. The positive correlation 
between node degree and biological essentiality 
has been confirmed recently [29, 30] but the 
original rationale has been challenged [30]. 
Zotenko et al.’s [30] proposition was that the hubs 
are essential because they form modules in which 
the member proteins are highly inter-connected 
and share a common biological function. They 
named the module as Essential Complex Biologi-
cal Module (ECOBIM) because it is enriched in 
essential proteins. Furthermore, the authors dem-
onstrated that current flow betweenness and 
shortest-path betweenness centralities are better 
indicators of connectivity, thus supporting the 
second view. So far, the above hypotheses were 
deduced from the yeast protein interaction network 
[27, 28, 30] and the human disease gene network 
[29] but how do they contribute to the current 
understanding of cancer biology?
The ﬁ  rst view seemed to agree with the recent 
suggestion that it could take three mutated genes 
or fewer to induce early stage malignancy [31] 
since some well studied cancer genes, e.g. APC, 
TP53, PTEN, and CDKN2A, have a degree 
centrality greater than 20 (see Fig. 2 in [32]). 
Further supporting evidence is that these genes are 
known to associate with familial cancers [33]. 
However, Goh et al. [29] demonstrated that the 
vast majority of disease genes do not encode 
proteins high in degree centrality and therefore are 
not essential except for diseases that are fatal 
in utero. If applied to oncology, that will suggest 
that carcinogenesis does not necessarily involve 
genes (or proteins) of high degree centralities.
In the network Ge’, the author observed that 
protein-coding genes that rank within the top 2% 
in degree centrality are not necessarily highly 
ranked in betweenness centralities. The best 
example comes from emergent group 1 in which 
RPL6, RPL9, RPL14, RPL15 and RPL31 rank 
within the top 2% in degree centrality but rank 
below 149th in current-ﬂ  ow centrality and rank 
below 100th in shortest-path betweenness centrality 
(Table 1). These genes are essential because RNA 
biosynthesis is fundamental to viability. The dele-
tion of any one gene will affect the connectivity 
within the emergent group 1 more than without. 
This observation is in agreement with Zotenko 
et al.’s view. On the other hand, genes that rank 
within the top 10% in degree centrality and also 
within the top 5% in closeness, current-ﬂ  ow close-
ness, current-ﬂ  ow betweenness, and shortest-path 
betweenness centralities, are involved in signal 
transduction or intracellular trafﬁ  cking suggesting 
that they could be the key drivers of disease pro-
gression if not carcinogenesis. Some of these 
proteins, e.g. CXCR4, RAN and IPO, are not only 
nodes within individual emergent groups but are 
also connected to liaison nodes and nodes of other 
emergent groups. Furthermore, a few signal trans-
duction proteins, e.g. CXCR4 and MAPK1, have 
degree centralities that rank within the top 2% and 
their current-ﬂ  ow betweenness and shortest-path 
betweenness centralities ranking within the top 
1%. They are likely to be signaling hubs [32]. 
Therefore, genes involved in HCC can have a high 
degree centrality but they can also serve as bottle-
neck proteins to multiple emergent groups. This 
deduction further reﬁ  nes Goh et al.’s proposition.
Thus far, none of the microRNA nodes found 
in Ge’ are emergent group nodes but are liaison 
nodes. Their degree centralities rank between 
252nd to 1314th with a median ranking of 569th. 
If projecting from Goh et al.’s and Zotenko et al.’s 
proposition, microRNAs are non-essential imply-
ing that their deletion may not be lethal but can 
contribute to abnormalities. Of the 15 microRNAs 
in Ge’, four of them rank within the top 3% in 
closeness centrality. They are MIRN148A, 
MIRN148B, MIRN217, and MIRN375. The ﬁ  rst 
two also rank within the top 2% in eccentricity. In 
addition, MIRN217 rank within the top 2% 
in shortest-path betweenness centrality and 
MIRN375 rank within the top 3% in current-ﬂ  ow 
betweenness and shortest-path betweenness cen-
tralities (Table 1). They share the common topo-
logical feature of being connected to liaison nodes 
on one side and emergent group nodes on the other 
side. Their ranking in the betweenness centralities 
seems to depend on the number of interaction 
partners and the node degree of each interaction 
partner. Based on the visualized topology and 
centrality rankings, it is reasonable to hypothesize 
that microRNAs which target signal transduction 
proteins or transcription factors of high degree, 
closeness, and betweenness centralities will exert 
the highest impact on the regulation of gene expres-
sion. This deduction seemed to agree with Cui 
et al.’s [34] proposition that the expression of the 
output layer genes in the signaling network is 
heavily regulated by microRNAs. Because the 471
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signal transduction network is inter-connected with 
the gene regulatory network [35], some proteins 
at the output layer could be bottlenecks that bridge 
the two networks and therefore are most likely to 
have high degree centralities as well as between-
ness centralities.
5. Conclusion
The use of actor-semiotic network modeling and 
analysis does provide insight into the pathology of 
HCC. Although the inclusion of semiotic nodes 
increases the size of a network, they are useful for 
identifying discrete clusters or emergent groups 
that serve a particular biological process or a set 
of inter-related molecular functions. The provisions 
of network decomposition and sub-network extrac-
tion functionalities by NetMap™ facilitated the 
‘top down’ exploration of a large graph. The use 
of graph signatures further facilitated network 
exploration by providing a summary of node 
topologies in a form of a scatterplot.
6. Methods
6.1. Data sources
Gene expression data. The gene co-expression 
proﬁ  les of HCC and normal hepatocytes were 
obtained from Gamberoni et al. [36] which was 
derived from the original dataset published by 
Chen et al. [37]. A set of co-expressed genes 
from each sample set (normal hepatocyte or HCC) 
was extracted based on their Pearson’s correlation 
coefﬁ  cients (PCC  0.86). This level of correla-
tion, according to the random matrix theory, 
should be adequate for differentiating between 
the true co-expression modules and random 
noise [38].
MicroRNA expression data. The microRNA 
expression data of HCC and adjacent normal hepa-
tocytes was published by Murakami et al. [15]. The 
predicted microRNA target genes were curated 
from three publications [39–41].
Gene Ontology. The three categories of GO―
Component, Process, and Function, were obtained 
from the Gene Ontology Consortium [42].
Human proteome data. The canonical human 
proteomic interaction data was obtained from the 
BioGrid version 2.0.36 [43]. This was integrated 
with the Hepatitis B-to-human proteomic interac-
tion data obtained from the NCBI Gene RIF.
6.2. Data-to-network mapping
A relational database was constructed for storing 
the above datasets. Data for the edges were stored 
in four tables with each storing data of a speciﬁ  c 
edge type. The mapping of data to nodes and edges 
was done with the use of NetMap Decision 
Director™. The actor nodes are GO Component, 
Gene, MIRNA, and Protein. The semiotic nodes 
are GO Process and GO Function. The semiotic 
edges are of the type Gene_To_GO (Process or 
Function). Inter-actor edge types are Gene_To_GO 
(Component), Gene_To_Gene, miRNA_To_Gene, 
and Gene_To_Protein. Gene_To_Gene has two 
subtypes: Coexpression_HCC and Coexpres-
sion_Liver. Gene_To_Protein also has two 
subtypes: Human_Protein_ Interaction and HBV_
Human_Interaction.
6.3. Network visualization 
and interactivity
The visualization for the networks described in this 
paper was generated with the use of NetMap™. 
The software also allows the analyst to (1) decom-
pose a large graph into a set of discrete clusters; 
(2) extract the largest cluster and identify its larg-
est connected component; (3) decompose the 
largest connected component to inter-connecting 
emergent groups; (4) navigate from point-to-point 
within each network; and (5) search nodes by Gene 
Symbols or GO identiﬁ  ers.
6.4. Emergent groups
The identiﬁ  cation of emergent groups was com-
pleted by a proprietary pattern recognition algo-
rithm embedded in NetMap™. These groups are 
so named because they emerge out of a given set 
of pairwise relationships. Hence, in a biological or 
social network, emergent groups are network 
structures that emerge out of local interactions [44]. 
The NetMap™ algorithm was employed to exam-
ine the topology and the edge types of the relevant 
network and emergent group nodes were identiﬁ  ed 
based on three criteria:
Given an emergent group Ce(Ve, Ee),
• | Ve|  2
•  Ee = Ve × Ve such that |Ee|  2.
• Each  node  v ∈ Ve has at least 50% of its edges 
connected to other nodes within Ce.
Under these criteria, Ce often appears as a sub-
network of high curvature which is the local 472
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density of triangular relations. Given that the 
curvature of a node, curv(v), is deﬁ  ned as:
curv v t
nn () () / = −12
where curv(v) = [0, 1], t is the number of triangles, 
and n is the number of neighbours to node v [45], 
curv(v)→1 in Ce.
6.5. Centrality measures
Node centralities are metrics for measuring the 
connectivity pattern of a node in relation to its 
surrounding neighbours. In this study, nine types 
of node centralities were calculated using CentiBiN 
[46]. They are closeness, current-ﬂ  ow between-
ness, current ﬂ  ow closeness, degree, eccentricity, 
HITS-authority, HITS-hub, radiality, and shortest-
path betweenness centralities. The rationale behind 
each measure can be found in [47].
6.6. Signature vectors
After computing each node centrality type, the 
nodes were ranked in the descending order of their 
centrality values. The node with the highest value 
for, say degree centrality, would be assigned a rank 
score of 1. Hence the lower is the rank score, the 
higher is the node ranking for a certain centrality 
type. This step generated a column vector R = [ci] 
for each centrality type in which each entry ci is 
the rank score for node i. The iteration of the pre-
vious step generated a set of column vectors 
S = (R0, R1, …, Rj) which formed the matrix M = [cij] 
in which each entry cij is the rank score for node i 
of the centrality type j. The node i can be an actor 
or a semiotic node. The signature vector Vi for node 
i is deﬁ  ned as Vi = (ci0, ci1, …, cij) which is the rowi 
of M. The matrix M was further factorized to give 
a smaller matrix M’ = [cik] for k  j if some of the 
column vectors in M were identical. The resulting 
signature vector V’i for node i is therefore the 
rowi of M’. Using Kruskal’s multi-dimensional 
scaling, the set of signature vectors {V’i} was then 
projected to a 2D space and visualized as a 
scatterplot [48].
6.7. Software availability
The NetMap Analytics™ software suite which 
includes NetMap Decision Director™ and 
NetMap™ is available from NetMap Analytics 
Proprietary Limited, Sydney, Australia (http://
www.netmapanalytics.com.au) under an academic 
license.
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A.1. Representation of network G
The input for generating G is a set of networks 
{G1, …,G6} in which:
•  G1(V1, E1, ρ) is the co-expression network where 
V1 is the set of Gene nodes, E1 is the set of 
pairwise gene co-expression relationships 
deﬁ  ned by the Pearson correlation (PCC  0.86), 
and ρ is the phenotype label which can be 
Coexpression_HCC or Coexpression_Liver.
•  G2(V2, E2, ε) is the protein interaction network 
where V2 is the set of Protein nodes, E2 is 
the set of pairwise protein interactions, and 
ε is the interaction type which can be 
Human_Protein_Interaction or HBV_Human_
Interaction.
•  G3(V31 ∪ V32, E3) is the microRNA regulatory 
network where V31 is the set of MIRNA nodes, 
V32 is the set of Gene nodes, and E3 is the set 
of predicted pairwise microRNA-to-Gene 
interactions. Given that there are two sets of 
inter-connected nodes, G3 is a bipartite 
graph.
•  G4(V41 ∪ V42, E4) is the GO Process-to-Gene 
network where V41 is the set of GO Process nodes, 
V42 is the set of Gene nodes, and E4 is the set of 
semiotic relationships between the GO Process 
and Gene nodes. Given that there are two sets of 
inter-connected nodes, G4 is a bipartite graph.
•  G5 and G6 are the GO Function-to-Gene and 
GO Component-to-Gene networks respectively. 
Their graph theoretic deﬁ  nition is similar to that 
of G4. It should be noted that GO Component 
is being classiﬁ  ed as an actor rather than a 
semiotic node because it is an abstraction of a 
physical intracellular structure.






= ∪ 1  where k = 6
A.2. Representation of network G’
In addition to the set of networks listed above, the 
inputs for generating G’ are:
•  The node set common to G1 and G2 is deﬁ  ned 
in the 1:1 mapping R1:V11 ↔ V22 where V11 ⊆ 
V1 and V22 ⊆ V2.
•  The node set common to G1 and G3 is deﬁ  ned in 
the 1:1 mapping between their Gene nodes such 
that R2:V11 ↔ V33 where V11 ⊆ V1 and V33 ⊆ V32.
•  The mapping between G1 and the individual net-
works G4 to G6 is similar to the deﬁ  nition of R2.
The output network G’ is therefore a result of 
G12 ∪ G13 ∪ G14 ∪ G15 ∪ G16 of which:
•  G12(V12, E12) is derived from G1 and G2 where 
V12 = V1∩V2, and the edge set E12 is the subset 
of E1 ∪ E2, i.e.
Ee E e E e E e e e 12 12 1 1 2 2 1 2 =∈ ∃ ∈ ∈ ∪∈ {} |, ,
For those edges that are common to E1 and E2, 
i.e. e1 ↔ e2, they are being factorized to a single 
edge e1 but double the edge weight. Therefore E12 
contains three types of edges. The ﬁ  rst type repre-
sents both gene co-expression and pairwise protein 
interactions. The second type represents only gene 
co-expression and the last type represents only 
pairwise protein interactions.
•  G13(V131 ∪ V132, E13) is derived from G1 and G3 
where V132 is the Gene node set and V132 = 
V1∩V32. V131 is the set of MIRNA nodes whereas 
the edge set E13 is the subset of E3.
•  G14(V141 ∪ V142, E14) is derived from G1 and G4 
where V142 is the Gene node set and V142 = 
V1∩V42. V141 is the set of GO Process nodes 
whereas the edge set E14 is the subset of E4.
•  G15 is derived from G1 and G5 whereas G16 is 
derived G1 and G6. The graph theoretic deﬁ  nition 
of G15 and G16 is similar to that of G14, except that 
G15 contains a set of GO Function nodes whereas 
G16 contains a set of GO Component nodes.